桂龙通络胶囊与微创颅内血肿清除术治疗对脑出血预后的影响  

Guilong Tongluo Capsule and Minimally Invasive Treatment of Intracranial Hematoma on the Prognosis of Cerebral Hemorrhage

作　　者：赵新民[1] 李新萍[1] 张欣[1] 肖维刚[1] 冯彦敏[1] 靳彦华[1] 

机构地区：[1]河北以岭医院脑内科,以岭050091

出　　处：《中国医药导刊》2008年第4期576-577,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:探讨桂龙通络胶囊加微创颅内血肿清除术(以下简称微创术)治疗高血压性脑出血的临床疗效。方法:将94例高血压性脏出血患者随机分为对照组(微创术组)和治疗组(桂龙通络胶囊加微创术),治疗3周后观察疗效。结果:对照组、治疗组总有效率分别为74.14%,94.64%,两组有显著性差异(P<0.05)。结论:桂龙通络胶囊+微创术治疗高血压性脑出血疗效优于单纯微创术治疗,可提高抢救成功率,降低死亡率及并发症。Objective：To explore the clinical efficacy of Guilong Tongluo capsule and the minimal invasive operation to eliminate intracranial hematoma in the treatment of hypertensive Cerebral hemorrhage. Methods： To divide randomly 94 cases of hypertensive cerebral hemorrhage into Control Group （minimally invasive operation group） and Treatment Group （Guilong Tongluo capsule and minimally invasive operation）. To observe treatment efficacy three weeks after treatment. Results： The total efficiency of Control Group and Treatment Group were 74. 14% and 94.64%, There were significant differences （P 〈 0. 05 ）, Conclusion： Guilong Tongluo capsule plus minimally invasive operation is superior to the single treatment of minimally invasive operation on hypertensive cerebral hemorrhage. It can improve the success rate of reseue, reduce mortality and complications

关 键 词：桂龙通络胶囊 微创颅内血肿清除术 高血压性脑出血 预后 影响因素 

分 类 号：R651.12[医药卫生—外科学]